1Grennan DM, Parfitt A, Manolios N, et al. Family and twin studies in systemic lupus erythematosus [ J]. Dis Markers, 1997, 13 (2):93-98.
2Donner H, Rau H, Walfish PC,et al.CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus [ J ]. J Clin Endocrinol Metab, 1997, 82(1) : 143 - 146.
3Ahmed S, Ihara K, Kanemitsu S, et al.Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population [ J]. Rheumatology (Oxford), 2001, 40 (6):662- 667.
4Eagar TN, Karandikar NJ, Bluestone JA, et al. The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance[J]. Eur J Immunlo , 2002, 32 (4) :972 - 981.
5Takiguchi M, Murakami M, Nakagawa I, et al. CTIA-4IgG gene delivery prevents autoantibody production and lupus nephritis in MRL/lpr mice[J]. Life Sci , 2000 , 66(11): 991 - 1 001.
6Barreto M. Santos E. Ferreira R. et al. Evidence for CTLA4 as a sus-ceptibility gene for systemic lupus erythematosus[ J]. Nature,2004,12:620 - 626.
7Waterhouse P. Penninger JM. Timms E. et al. Lymphoproliferative disorders with early lethality in mice deficient in CTLA -4 [J]. Science, 1995,270:985 - 988.
8Harper K. Balzano C. Rouvier E. et al. A CTLA -4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure,and chromosoma location [J]. J Immunol, 1991, 147:1037 - 1044.
9Parks CG, Hudson LL, Cooper GS, et al. CTLA - 4 gene polymorphisms and systemic lupus erythematosus in a population - based study of whites and African -Americans in the southeastern United States [ J ]. Lupus, 2004,13:784.
10Hudson LL, Rocca K, Song YW, et al. CTLA - 4 gene polymorphisms in systemic lupus erythematosus:a highly significant association with a determinant in the promoter region [ J] . Hum Genet,2002,111:452 - 455.
